Wells Pharmacy Network
Multi-site network running a 503A pharmacy in Florida and a 503B outsourcing facility in Tennessee. Named publicly by . What is checkable, and how to check it.
Updated 2026-09-18
Wells Pharmacy Network turns up in the supply chain behind GLP-1 prescriptions. Here is its public record, which is not the same thing as its marketing.
No provider we review names this pharmacy publicly. It appears here because it is widely reported as supplying compounded GLP-1s and because it has a published FDA record worth being able to look up — you may well be dispensed from it without ever being told.
Why the desk tracks pharmacies at all
Because it is the one part of this market with a federal paper trail. Telehealth companies publish whatever they like about themselves. Compounding pharmacies get inspected, and the FDA publishes what it found — dates, document types, warning letters, recalls. It is the only independently verifiable information in the entire category, and almost nobody puts it in front of readers.
What we can verify about Wells Pharmacy Network
| Wells Pharmacy Network | |
|---|---|
| Facility type | 503A pharmacy (Ocala, FL) and 503B outsourcing facility (Dyersburg, TN) |
| Location | Ocala, Florida and Dyersburg, Tennessee |
| Accreditation | None published |
| Named publicly by | No provider we review names it |
| FDA actions published | Yes — 8 entries |
- FDA lists two separate facilities: Wells Pharmacy Network, LLC in Ocala, Florida as a 503A, and Wells Pharmacy Network LLC in Dyersburg, Tennessee as a 503B outsourcing facility.
- Reported as offering semaglutide, tirzepatide and liraglutide formulations.
That is the complete list of what we could confirm from published sources as of 2026-09-18. We have not filled the gaps with inference — if something is not above, we could not verify it.
Our read
The two-facility structure is the thing to understand. A 503A and a 503B under one brand means your prescription could be filled under either regime — state-board oversight or direct FDA inspection — and they have markedly different published records. The Tennessee 503B carries entries running into 2026; the Florida 503A has a single 2020 letter. If a provider tells you your medication comes from Wells, the useful follow-up is which site.
FDA enforcement record
FDA publishes inspections, recalls and other actions for compounders. The entry below is quoted from that list as FDA states it. Read the glossary before drawing conclusions — most of these documents are not what people assume.
Listed as: Two entries: Wells Pharmacy Network, LLC, Ocala, FL — 503A Facility, and Wells Pharmacy Network LLC, Dyersburg, TN — 503B Facility
- 503A (Ocala, FL): FMD-145 Letter Issued 06/8/2020
- 503B (Dyersburg, TN): 483 issued 4/09/2026
- 503B (Dyersburg, TN): FMD-145 Letter Issued 03/26/2026
- 503B (Dyersburg, TN): Untitled Letter Issued 10/14/2025
- 503B (Dyersburg, TN): 483 Issued 04/25/2025
- 503B (Dyersburg, TN): Untitled Letter Issued 05/19/2022
- 503B (Dyersburg, TN): 483 Issued 01/28/2021
- 503B (Dyersburg, TN): FMD-145 Letter Issued 08/06/2020
Our note. No warning letter appears against either facility. The two sites are listed separately by FDA and their records should not be read as one.
Read this bit. How to read this fairly. A Form 483 records inspection observations, not proven violations, and a busy facility that FDA visits often will collect more of them than one nobody inspects. Absence from the list is not a clean bill of health — it can simply mean no inspection or no published action. And the legal entity matters: similarly-named companies are frequently different facilities with different records.
What each document type actually means is explained once on the pharmacies index. Source: FDA, checked 2026-09-18.
The step-by-step way to check a pharmacy licence yourself — state boards, PCAB, NABP and what to ask for — is set out once on the pharmacies index rather than repeated on every page.
Where to get a GLP-1 prescription
A compounding pharmacy cannot sell you a GLP-1 directly — it fills a prescription written by a licensed clinician. So the practical route is a telehealth provider who prescribes and arranges dispensing.
Our featured provider is [Coreage Rx](/reviews/coreage-rx-tirzepatide-reviews), which prices compounded tirzepatide from $149 a month and semaglutide from $99 on the annual plan, flat at every dose and with no membership fee. That is a paid placement and we say so on every page it appears — see our disclosure. Check current pricing.
Read this bit. An honest caveat about our own recommendation. Coreage Rx does not publish which compounding pharmacy fills its prescriptions, so we cannot tell you it uses this one or any other — and we are not going to imply it. If pharmacy provenance is your priority, the providers that do name their pharmacies are listed on who names their pharmacy. Ask any provider the question directly and get the answer in writing.
Common questions
Can I buy from Wells Pharmacy Network directly?
No. A compounding pharmacy dispenses against a prescription from a licensed clinician — it is not a shop. Anyone offering to sell you a compounded GLP-1 without a prescription is not operating legally, whatever pharmacy name is attached.
Does a named pharmacy mean the medication is FDA-approved?
No, and this is the distinction that matters most. A compounded preparation is not FDA-approved regardless of how well-regarded the pharmacy is. The pharmacy is licensed and may be accredited; the preparation itself has not been reviewed by the FDA for safety, effectiveness or manufacturing quality.
What is 503A, briefly?
A 503A pharmacy compounds for an individual patient against a specific prescription and is regulated primarily by state boards of pharmacy. A 503B outsourcing facility can produce larger batches, registers with the FDA and is subject to FDA inspection. Full explanation in is compounded GLP-1 still legal.
Read the record, read the glossary, and treat any ranking that praises a pharmacy without mentioning its record as what it is.
Verified 2026-09-18 from published sources. We are not affiliated with Wells Pharmacy Network and this is not an endorsement of any particular pharmacy — it is a record of what is publicly checkable.
More from the desk
- The pharmacies behind the prescriptions
The pharmacy is the part that is actually regulated — and most providers will not name theirs. Here are the ones that have been named publicly.
- The most transparent providers
Ranked on whether the advertised price is the billed price, and whether the company tells you where the medication comes from.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure